BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1851548)

  • 41. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
    Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Wilms' tumour as a paradigm for the relationship of cancer to development.
    Pritchard-Jones K; Hastie ND
    Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.
    Gerald WL; Gramling TS; Sens DA; Garvin AJ
    Am J Pathol; 1992 May; 140(5):1031-7. PubMed ID: 1316081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
    Simms LA; Algar EM; Smith PJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allelic loss on chromosome 11p is a less frequent event in bilateral than in unilateral Wilms' tumours.
    Little MH; Clarke J; Byrne J; Dunn R; Smith PJ
    Eur J Cancer; 1992; 28A(11):1876-80. PubMed ID: 1356388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytogenetic abnormalities in mesoblastic nephroma: a link to Wilms' tumour?
    Roberts P; Lockwood LR; Lewis IJ; Bailey CC; Batcup G; Williams J
    Med Pediatr Oncol; 1993; 21(6):416-20. PubMed ID: 8390601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours.
    Lemoine NR; Hughes CM; Cowell JK
    J Pathol; 1992 Oct; 168(2):237-42. PubMed ID: 1334142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
    Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
    Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of homozygosity for chromosome 11p markers in Wilms' tumour.
    Orkin SH; Goldman DS; Sallan SE
    Nature; 1984 May 10-16; 309(5964):172-4. PubMed ID: 6325937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid isolation of moderate and highly polymorphic DNA fragments mapping close to WT (Wilms' tumour) and AN2 (aniridia) on chromosome 11.
    Boyd PA; Christie S; Hastie ND; Porteous DJ
    Hum Genet; 1989 Mar; 81(4):349-52. PubMed ID: 2564837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of chromosome 11p alleles in cultured cells derived from Wilms' tumours.
    Brown KW; Shaw AP; Poirier V; Tyler SJ; Berry PJ; Mott MG; Maitland NJ
    Br J Cancer; 1989 Jul; 60(1):25-9. PubMed ID: 2553087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wilms' tumour: reconciling genetics and biology.
    Van Heyningen V; Hastie ND
    Trends Genet; 1992 Jan; 8(1):16-21. PubMed ID: 1369730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Definition of the limits of the Wilms tumor locus on human chromosome 11p13.
    Compton DA; Weil MM; Bonetta L; Huang A; Jones C; Yeger H; Williams BR; Strong LC; Saunders GF
    Genomics; 1990 Feb; 6(2):309-15. PubMed ID: 2155176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.
    Lai YC; Lu MY; Wang WC; Hou TC; Kuo CY
    Int J Exp Pathol; 2022 Jun; 103(3):121-128. PubMed ID: 35436013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.
    Huff V
    Nat Rev Cancer; 2011 Feb; 11(2):111-21. PubMed ID: 21248786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a new WT1 mutation in a sporadic Wilms' tumour.
    Santos AC; Boavida MG; Costa A; Osorio-Almeida L
    Biochim Biophys Acta; 1998 Aug; 1407(2):109-13. PubMed ID: 9685601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SKCG-1: a new candidate growth regulatory gene at chromosome 11q23.2 in human sporadic Wilms tumours.
    Singh KP; Roy D
    Br J Cancer; 2006 May; 94(10):1524-32. PubMed ID: 16622458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.